AHN-GOOK PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7,780 KRW | -0.26% |
|
+1.83% | -17.32% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2022 | 21TCr 15Cr 1.27TCr | Sales 2023 | 23TCr 17Cr 1.44TCr | Capitalization | 11TCr 7.91Cr 658.71Cr |
|---|---|---|---|---|---|
| Net income 2022 | 687.5Cr 50.88L 42Cr | Net income 2023 | 129Cr 10L 7.95Cr | EV / Sales 2022 | 0.42 x |
| Net cash position 2022 | 1.84TCr 1.36Cr 113.56Cr | Net cash position 2023 | 1.78TCr 1.31Cr 109.43Cr | EV / Sales 2023 | 0.38 x |
| P/E ratio 2022 |
15.2
x | P/E ratio 2023 |
82.9
x | Employees | 376 |
| Yield 2022 |
2.39% | Yield 2023 |
2.34% | Free-Float | 38.16% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.26% | ||
| 1 week | +1.83% | ||
| Current month | +1.97% | ||
| 1 month | +2.50% | ||
| 3 months | -8.25% | ||
| 6 months | +1.57% | ||
| Current year | -17.32% |
1 week
7 610.00
7 810.00
1 month
7 500.007 810.00
Current year
7 390.0010 160.00
1 year
7 150.0010 510.00
3 years
7 140.0015 000.00
5 years
6 300.0020 650.00
10 years
6 300.0034 250.00
| Managers | Title | Age | Since |
|---|---|---|---|
Jin Oh
CEO | Chief Executive Officer | 60 | - |
Jun-Sun Oh
CEO | Chief Executive Officer | 87 | - |
Deok-Gwon Won
PSD | President | 60 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jun-Sun Oh
CEO | Chief Executive Officer | 87 | - |
Jin Oh
CEO | Chief Executive Officer | 60 | - |
Deok-Gwon Won
PSD | President | 60 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/24/17 | 7,780 | -0.26% | 18,708 |
| 16/24/16 | 7,800 | +1.69% | 17,196 |
| 14/24/14 | 7,670 | +0.13% | 8,993 |
| 13/24/13 | 7,660 | +0.26% | 13,189 |
| 10/24/10 | 7,640 | -0.52% | 13,781 |
End-of-day quote Korea S.E., May 17, 2024
More quotes
AHN-GOOK PHARMACEUTICAL Co., Ltd. is a Korea-based company engaged in the manufacture of pharmaceuticals. The Companyâs products include respiratory agents, gastrointestinal agents, anti-inflammatory, analgesic agents, ophthalmic agents and circulatory system agents. It also provides antibiotic, antifungal drugs, antihyperlipidemic agents, antiallergic drugs, anti-diabetic drugs, urinary system drugs and skin disease remedies. In addition, the Company provides other over the counter (OTC) and ethical (ETC) drugs. The Company distributes its product within domestic market and to overseas markets.
Sector
Pharmaceuticals
Calendar
13/08/2024
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -17.32% | 6.53Cr | |
| +21.63% | 4.41TCr | |
| +23.03% | 2.27TCr | |
| +18.22% | 1.51TCr | |
| +12.66% | 1.36TCr | |
| +60.18% | 1.27TCr | |
| -10.02% | 684.06Cr | |
| -0.05% | 678.76Cr | |
| -8.87% | 572.55Cr | |
| +12.92% | 562.63Cr |
- Stock Market
- Equities
- A001540 Stock
